QQ客服 官方微博 反馈留言

	TAT-fused IP3R-derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release
	Xie, Qi; Xu, Ye; Gao, Weinan; Zhang, Yong; Su, Jing; Liu, Yanan; Guo, Yuting; Dou, Minghan; Hu, Kebang; Sun, Liankun
刊名	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
	2018
卷号	41期号:2
关键词	cisplatin ovarian cancer calcium endoplasmic reticulum peptide
ISSN号	1107-3756
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3536630
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Xie, Qi,Xu, Ye,Gao, Weinan,et al. TAT-fused IP3R-derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release[J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE,2018,41(2).
APA	Xie, Qi.,Xu, Ye.,Gao, Weinan.,Zhang, Yong.,Su, Jing.,...&Sun, Liankun.(2018).TAT-fused IP3R-derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release.INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE,41(2).
MLA	Xie, Qi,et al."TAT-fused IP3R-derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release".INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 41.2(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。